Matches in SemOpenAlex for { <https://semopenalex.org/work/W2118935462> ?p ?o ?g. }
- W2118935462 endingPage "633" @default.
- W2118935462 startingPage "626" @default.
- W2118935462 abstract "The combination of cyclophosphamide, doxorubicin, vincristine, and prednisone, given every 3 weeks (CHOP-21) is standard chemotherapy for aggressive lymphomas. To determine whether CHOP given every 2 weeks (CHOP-14) or the addition of etoposide (CHOEP-21, CHOEP-14) can improve results in patients ages 18 to 60 years with good prognosis (normal lactic dehydrogenase [LDH] level), 710 patients were randomized to 6 cycles of CHOP-21, CHOP-14, CHOEP-21 (CHOP plus etoposide 100 mg/m2 days 1-3), or CHOEP-14 in a 2 x 2 factorial study design. Patients in the biweekly regimens received granulocyte colony-stimulating factor (G-CSF) starting from day 4. Patients received radiotherapy (36 Gy) to sites of initial bulky disease and extranodal disease. CHOEP achieved better complete remission (87.6% versus 79.4%; P =.003) and 5-year event-free survival rates (69.2% versus 57.6%; P =.004, primary end point) than CHOP, whereas interval reduction improved overall survival (P =.05; P =.044 in the multivariate analysis). Although the CHOEP regimens induced more myelosuppression, all regimens were well tolerated. CHOEP should be the preferred chemotherapy regimen for young patients with good-prognosis (normal LDH level) aggressive lymphoma." @default.
- W2118935462 created "2016-06-24" @default.
- W2118935462 creator A5002498295 @default.
- W2118935462 creator A5009186146 @default.
- W2118935462 creator A5014979722 @default.
- W2118935462 creator A5020056951 @default.
- W2118935462 creator A5023251571 @default.
- W2118935462 creator A5025964385 @default.
- W2118935462 creator A5026240360 @default.
- W2118935462 creator A5029063148 @default.
- W2118935462 creator A5039235274 @default.
- W2118935462 creator A5042300762 @default.
- W2118935462 creator A5052479430 @default.
- W2118935462 creator A5069362146 @default.
- W2118935462 creator A5082950855 @default.
- W2118935462 creator A5090490279 @default.
- W2118935462 date "2004-04-08" @default.
- W2118935462 modified "2023-10-12" @default.
- W2118935462 title "Two-weekly or 3-weekly CHOP chemotherapy with or without etoposide for the treatment of young patients with good-prognosis (normal LDH) aggressive lymphomas: results of the NHL-B1 trial of the DSHNHL" @default.
- W2118935462 cites W1912693401 @default.
- W2118935462 cites W1946151534 @default.
- W2118935462 cites W1946633639 @default.
- W2118935462 cites W1979300931 @default.
- W2118935462 cites W1999822150 @default.
- W2118935462 cites W2058015212 @default.
- W2118935462 cites W2087824134 @default.
- W2118935462 cites W2099090406 @default.
- W2118935462 cites W2107202569 @default.
- W2118935462 cites W2108465006 @default.
- W2118935462 cites W2129319674 @default.
- W2118935462 cites W2135826545 @default.
- W2118935462 cites W2161026651 @default.
- W2118935462 cites W2318772898 @default.
- W2118935462 cites W2327610290 @default.
- W2118935462 cites W2338856174 @default.
- W2118935462 cites W2512906422 @default.
- W2118935462 cites W2605539363 @default.
- W2118935462 doi "https://doi.org/10.1182/blood-2003-06-2094" @default.
- W2118935462 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/14982884" @default.
- W2118935462 hasPublicationYear "2004" @default.
- W2118935462 type Work @default.
- W2118935462 sameAs 2118935462 @default.
- W2118935462 citedByCount "440" @default.
- W2118935462 countsByYear W21189354622012 @default.
- W2118935462 countsByYear W21189354622013 @default.
- W2118935462 countsByYear W21189354622014 @default.
- W2118935462 countsByYear W21189354622015 @default.
- W2118935462 countsByYear W21189354622016 @default.
- W2118935462 countsByYear W21189354622017 @default.
- W2118935462 countsByYear W21189354622018 @default.
- W2118935462 countsByYear W21189354622019 @default.
- W2118935462 countsByYear W21189354622020 @default.
- W2118935462 countsByYear W21189354622021 @default.
- W2118935462 countsByYear W21189354622022 @default.
- W2118935462 countsByYear W21189354622023 @default.
- W2118935462 crossrefType "journal-article" @default.
- W2118935462 hasAuthorship W2118935462A5002498295 @default.
- W2118935462 hasAuthorship W2118935462A5009186146 @default.
- W2118935462 hasAuthorship W2118935462A5014979722 @default.
- W2118935462 hasAuthorship W2118935462A5020056951 @default.
- W2118935462 hasAuthorship W2118935462A5023251571 @default.
- W2118935462 hasAuthorship W2118935462A5025964385 @default.
- W2118935462 hasAuthorship W2118935462A5026240360 @default.
- W2118935462 hasAuthorship W2118935462A5029063148 @default.
- W2118935462 hasAuthorship W2118935462A5039235274 @default.
- W2118935462 hasAuthorship W2118935462A5042300762 @default.
- W2118935462 hasAuthorship W2118935462A5052479430 @default.
- W2118935462 hasAuthorship W2118935462A5069362146 @default.
- W2118935462 hasAuthorship W2118935462A5082950855 @default.
- W2118935462 hasAuthorship W2118935462A5090490279 @default.
- W2118935462 hasConcept C126322002 @default.
- W2118935462 hasConcept C143998085 @default.
- W2118935462 hasConcept C2776694085 @default.
- W2118935462 hasConcept C2778119113 @default.
- W2118935462 hasConcept C2779338263 @default.
- W2118935462 hasConcept C2779725641 @default.
- W2118935462 hasConcept C2780653079 @default.
- W2118935462 hasConcept C2781214270 @default.
- W2118935462 hasConcept C71924100 @default.
- W2118935462 hasConcept C90924648 @default.
- W2118935462 hasConceptScore W2118935462C126322002 @default.
- W2118935462 hasConceptScore W2118935462C143998085 @default.
- W2118935462 hasConceptScore W2118935462C2776694085 @default.
- W2118935462 hasConceptScore W2118935462C2778119113 @default.
- W2118935462 hasConceptScore W2118935462C2779338263 @default.
- W2118935462 hasConceptScore W2118935462C2779725641 @default.
- W2118935462 hasConceptScore W2118935462C2780653079 @default.
- W2118935462 hasConceptScore W2118935462C2781214270 @default.
- W2118935462 hasConceptScore W2118935462C71924100 @default.
- W2118935462 hasConceptScore W2118935462C90924648 @default.
- W2118935462 hasIssue "3" @default.
- W2118935462 hasLocation W21189354621 @default.
- W2118935462 hasOpenAccess W2118935462 @default.
- W2118935462 hasPrimaryLocation W21189354621 @default.
- W2118935462 hasRelatedWork W2006707835 @default.
- W2118935462 hasRelatedWork W2056585489 @default.
- W2118935462 hasRelatedWork W2078839423 @default.
- W2118935462 hasRelatedWork W2110119190 @default.